{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:21Z","timestamp":1786119441314,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/mjt.0b013e3181b0a6ff","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T04:15:25Z","timestamp":1269404125000},"page":"91-98","source":"Crossref","is-referenced-by-count":1,"title":["Effects of FX06 In Vitro on Platelet, Coagulation, and Fibrinolytic Biomarkers in Volunteers and Patients With Documented Coronary Artery Disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Jonas","family":"Hall\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Serebruany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030.","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"R2-6-20210202","first-page":"1713","article-title":"Myocardial reperfusion: a double-edged sword J Clin Invest.","volume":"76","author":"Braunwald","year":"1985","journal-title":""},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMe0803746","article-title":"Time to take myocardial reperfusion injury seriously.","volume":"359","author":"Hausenloy","year":"2008","journal-title":"N Engl J Med"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cardiores.2007.01.014","article-title":". Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.","volume":"74","author":"Dirksen","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00109-006-0051-7","article-title":". Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction.","volume":"84","author":"Zacharowski","year":"2006","journal-title":"J Mol Med"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2008.12.017","article-title":". Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.","volume":"53","author":"Atar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","article-title":"Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.","volume":"61","author":"Gawaz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1152\/ajplegacy.1935.112.2.351","article-title":"The effect of coronary occlusion on myocardial contraction.","volume":"112","author":"Tennant","year":"1935","journal-title":"Am J Physiol"},{"key":"R9-6-20210202","first-page":"68","article-title":". Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.","volume":"70","author":"Jennings","year":"1960","journal-title":"Arch Pathol"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","article-title":"Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.","volume":"61","author":"Vinten-Johansen","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R11-6-20210202","first-page":"491","article-title":"Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.","volume":"76","author":"Bazzoni","year":"1991","journal-title":"Haematologica"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm1198","article-title":". The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury.","volume":"11","author":"Petzelbauer","year":"2005","journal-title":"Nat Med"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1182\/blood.V81.9.2348.2348","article-title":". Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42.","volume":"81","author":"Hamaguchi","year":"1993","journal-title":"Blood"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"H692","DOI":"10.1152\/ajpheart.00634.2005","article-title":". Activated platelets contribute importantly to myocardial reperfusion injury.","volume":"290","author":"Xu","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1096\/fj.01-0199com","article-title":"Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure.","volume":"15","author":"Singbartl","year":"2001","journal-title":"FASEB J"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.embor.7401147","article-title":"Complexity in biology. Exceeding the limits of reductionism and determinism using complexity theory.","volume":"9","author":"Mazzocchi","year":"2008","journal-title":"EMBO Rep"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.embor.7400284","article-title":"eductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism.","volume":"5","author":"Van Regenmortel","year":"2004","journal-title":"EMBO Rep"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/sj.embor.7400180","article-title":"The evolution of molecular biology.","volume":"5","author":"Kellenberger","year":"2004","journal-title":"EMBO Rep"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181b0a6ff","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:45Z","timestamp":1786040325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201403000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181b0a6ff","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}